The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
Amgen Foundation committed up to $12.5 million to support COVID-19 relief efforts
On Mar. 23, 2020, the Amgen Foundation announced an initial commitment of up to $12.5 million to support…
UC Davis researchers raceed to develop coronavirus solutions
On Mar. 20, 2020, Clinical pathologists, infectious disease physicians and scientists at the UC Davis Medical Center, California…
High-speed microscope captured fleeting brain signals
On Mar. 19, 2020, University of California, Berkeley, investigators have now built such a camera: a microscope that…
Sorrento and Celularity to initiate emergency allogeneic natural killer cell therapy development for Coronavirus infection
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
Nanomix received CE Mark for diagnostic panel that aids in rapid identification of life-threatening infections
On Dec. 4. 2019, Nanomix announced that the company had received CE Mark for its S1 Assay for…
UCSD researchers provided new insights into a key pathway that controls critical cell division mechanisms
On Nov. 20, 2019, University of California San Diego (UCSD) researchers provided new insights into a key pathway…
Amgen and Duke Clinical Research Institute initiated first large-scale registry to evaluate real-world lipid management
On Nov. 15, 2019, Amgen and the Duke Clinical Research Institute announced plans to initiate first large-scale registry…
Researchers at UCSD School of Medicine successfully applied phage therapy in mice to treat alcohol-related liver disease
On Nov. 13, 2019, researchers at University of California San Diego (UCSD) School of Medicine announced that they…
Merck acquired San Diego’s Calporta for up to $576 million
On Nov. 12, 2019, Calporta Therapeutics, one of eight San Diego biotech companies Avalon Ventures created with GlaxoSmithKline,…
Genentech announced FDA approval of antiviral drug Xofluza (Baloxavir Marboxil)
On Oct. 17, 2019, Genentech announced the U.S. Food and Drug Administration (FDA) had approved Xofluza (Baloxavir Marboxil),…
deCODE in Iceland agreed to sequence half of UK Biobank participants, largest ever undertaken
On Sept. 11, 2019, deCODE genetics in Iceland announced an agreement with a consortium of government, charity, researchers…
Eleventh U.S. CRISPR-Cas9 Patent Awarded to University of California, U Vienna, Charpentier
On Aug. 20, 2019, the eleventh U.S. CRISPR-Cas9 patent was awarded to University of California, the University of…
Genentech drug Polivy (polatuzumab vedotin-piiq) granted accelerated approval by FDA
On Jun. 10, 2019, Genentech drug Polivy (polatuzumab vedotin-piiq) announced the U.S. Food and Drug Administration (FDA) had…
Amgen announced the launch of Amgen Community Oncology Research Collaborators
On May 28, 2019, Amgen, along with leading community oncology networks, announced the launch of Amgen Community Oncology…
Amgen announced FDA approval of EVENITY for the treatment of osteoporosis
On Apr. 9 2019, Amgen announced U.S. Food and Drug Administration (FDA) approval of EVENITY (romosozumab-aqqg) for the…
The Priestley Medal was awarded to K. Barry Sharpless
On Mar. 31, 2019, the American Chemical Society awarded the Priestley Medal to K. Barry Sharpless “to recognize…
Biotechnology | Disease | FDA | Oncology | Therapeutics
The FDA approved new formulation of Herceptin for subcutaneous use
On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…
deCODE published the first full resolution genetic map of the human genome
On Jan. 24, 2019, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published the first genetic…
AstraZeneca closed Boulder-based LakeCentre and Longmont facilities
On Jan. 9, 2019, AstraZeneca announced it had closed plants in Colorado and layed off 210 workers. AstraZeneca…
The Earth BioGenome Project was founded
On Nov. 1, 2018, the Earth BioGenome Project (EBP) was launched, a global effort to sequence the genetic…
Researchers at JCVI, UCSD, and Scripps Oceanography discovered genetic basis for how harmful algal blooms become toxic
On Sept. 27, 2018, Researchers from Scripps Institution of Oceanography at UCSD and the J. Craig Venter Institute…
Cancer registry managed by Keck School of Medicine of USC received $43.7 million award
On May 21, 2018, the National Cancer Institute awarded Keck School of Medicine of USC and USC Norris…
UCLA researchers characterized the mechanism of the mammalian EAK-7 gene, or mEAK-7
On May 14, 2018, University of California, Los Angeles (UCLA) researchers characterized the mechanism of the mammalian EAK-7…
Amgen announced Rhode Island as location of first US next-generation biomanufacturing plant
On Apr. 10, 2018, Amgen announced plans to build a new state-of-the-art next-generation biomanufacturing plant at its 75-acre…
USC scientists launched global effort to find the next diabetes drug
On Mar. 23, 2018, University of Southern California (USC) researchers launched a massive scientific effort to construct a…
The Priestley Medal was awarded to Geraldine Richmond
On Mar. 19, 2018, the Priestley Medal was awarded to Geraldine Richmond by the American Chemical Society “to…
Norris Healthcare Center opened for patient care
On Mar. 9, 2018, the Keck Medicine of University of Southern California (USC) significantly expanded its patient care…
Biotechnology | Disease | FDA | Oncology | Therapeutics
FDA approved first biosimilar for the treatment of certain breast and stomach cancers
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
Disease | FDA | Therapeutics
Genentech drug Hemlibra (emicizumab-kxwh) was approved
On Nov. 16, 2017, the the U.S. Food and Drug Administration (FDA) approved the Genentech drug Hemlibra (emicizumab-kxwh)…